Stop using nowDrug recall · FDA · Published May 14, 2024
Imprimis NJOF Klarity-C Ophthalmic Drops Recall: Risk of Contaminated Eye Drops
Imprimis NJOF recalls Klarity-C (cyclosporine) eye drops due to lack of sterility assurance. This compounded drug may cause infection if used. Stop using and contact your doctor.
“Imprimis NJOF Klarity-C Ophthalmic Drops Recall: Risk of Contaminated Eye Drops.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32676-imprimis-njof-klarity-c-ophthalmic-drops-recall-risk-of-contaminated. Based on FDA recall #D-0547-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0547-2024%22&limit=1).
The FDA announced on May 14, 2024, that Imprimis NJOF, LLC is recalling Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion due to a lack of assurance of sterility. The recall affects 136,005 units distributed nationwide.
The product is recalled because of a lack of assurance of sterility. The FDA classified the recall as Class II.
Context
GovInfoNow's records show Imprimis NJOF, LLC has had 13 other recalls since December 17, 2020. Recent brand recalls include an Imprimis Tri-Moxi+ Intraocular Injection recall on December 18, 2025, for glass particles risk, and a Klarity-C Drops recall on October 20, 2025, for subpotent drug risk. Other recent recalls of similar products include K.C. Pharmaceuticals Sterile Eye Drops AC Recall (March 3, 2026) and K.C. Pharmaceuticals Ultra Lubricating Eye Drops Recall (March 3, 2026), both citing lack of sterility risk.
How to tell if you have this one
Check for the product name 'Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL' on the label. Look for the lot numbers listed in the recall (e.g., 23APR005, 23MAY024) with expiration dates up to 10/11/2024.
Brand
Imprimis NJOF
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Immediately stop using any Klarity-C eye drops from the recalled lots.
Contact Your Doctor
Talk to your healthcare provider about alternative treatments or proper disposal of the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 36 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0547-2024 (May 14, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0547-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.